S'abonner

miR103a-3p in extracellular vesicles from Fc?RI-aggregated human mast cells enhances IL-5 production by group 2 innate lymphoid cells - 05/05/21

Doi : 10.1016/j.jaci.2021.01.002 
Shota Toyoshima, PhD a, b, c, Tomomi Sakamoto-Sasaki, MSc a, b, c, Yusuke Kurosawa, MD a, b, d, Koremasa Hayama, MD, PhD b, e, Akira Matsuda, MD, PhD f, Yasuo Watanabe, BSc f, Tadashi Terui, MD, PhD b, e, Yasuhiro Gon, MD, PhD b, d, Kenji Matsumoto, MD, PhD g, Yoshimichi Okayama, MD, PhD a, b, c,
a Allergy and Immunology Research Project Team, Research Institute of Medical Science, Nihon University School of Medicine, Tokyo, Japan 
b Center for Allergy, Nihon University Itabashi Hospital, Tokyo, Japan 
c Center for Medical Education, Nihon University School of Medicine, Tokyo, Japan 
d Division of Respiratory Medicine, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan 
e Divison of Cutaneous Science, Department of Dermatology, Nihon University School of Medicine, Tokyo, Japan 
f Department of Ophthalmology, Juntendo University Graduate School of Medicine, Tokyo, Japan 
g Department of Allergy and Clinical Immunology, National Research Institute for Child Health and Development, Tokyo, Japan 

Corresponding author: Yoshimichi Okayama, MD, PhD, Allergy and Immunology Research Project Team, Research Institute of Medical Science, Center for Allergy, Center for Medical Education, Nihon University School of Medicine, 30-1 Oyaguchi-kamicho, Itabashi-ku, Tokyo 173-8610, Japan.Allergy and Immunology Research Project TeamResearch Institute of Medical ScienceCenter for AllergyCenter for Medical EducationNihon University School of Medicine30-1 Oyaguchi-kamichoItabashi-kuTokyo173-8610Japan

Abstract

Background

Mast cells (MCs) are key regulators of IgE-mediated allergic inflammation. Cell-derived extracellular vesicles (EVs) contain bioactive compounds such as microRNAs. EVs can transfer signals to recipient cells, thus using a novel mechanism of cell-to-cell communication. However, whether MC-derived EVs are involved in FcεRI-mediated allergic inflammation is unclear.

Objective

We sought to investigate the effect of EVs derived from FcεRI-aggregated human MCs on the function of human group 2 innate lymphoid cells (ILC2s).

Methods

Human cultured MCs were sensitized with and without IgE for 1 hour and then incubated with anti-IgE antibody, IL-33, or medium alone for 24 hours. EVs in the MC supernatant were isolated by using ExoQuick-TC.

Results

Coculture of ILC2s with EVs derived from the FcεRI-aggregated MCs significantly enhanced IL-5 production and sustained upregulation of IL-5 mRNA expression in IL-33–stimulated ILC2s, but IL-13 production and IL-13 mRNA expression were unchanged. miR103a-3p expression was upregulated in IL-33–stimulated ILC2s that had been cocultured with EVs derived from anti-IgE antibody–stimulated MCs. Transduction of an miR103a-3p mimic to ILC2s significantly enhanced IL-5 production by IL-33–stimulated ILC2s. miR103a-3p promoted demethylation of an arginine residue of GATA3 by downregulating protein arginine methyltransferase 5 (PRMT5) mRNA. Reduction of protein arginine methyltransferase 5 expression in ILC2s by using a small interfering RNA technique resulted in upregulation of IL-5 production by IL-33–stimulated ILC2s. Furthermore, the level of miR103a-3p expression was significantly higher in EVs from sera of patients with atopic dermatitis than in EVs from nonatopic healthy control subjects.

Conclusion

Eosinophilic allergic inflammation may be exacerbated owing to ILC2 activation by MC-derived miR103a-3p.

Le texte complet de cet article est disponible en PDF.

Key words : Extracellular vesicles, human mast cells, group 2 innate lymphoid cells, IL-5, miRNA103a-3p, methylated arginine residue, protein arginine methyltransferase 5

Abbreviations used : AD, EM, EV, ILC2, IMDM, MC, miRNA, NC, PGD2, PRMT, siRNA, Tg, 3'UTR


Plan


 Supported in part by a Grant-in-Aid for Early-Career Scientists (19K17687 [to S.T.]) and a Grant-in-Aid for Scientific Research from the MEXT of the Japanese Government (20K08811 [to Y.O.]), the Nihon University Research Grant for Social Implementation for 2020 (project No. Sya20-1201 [to Y.O.]), and the MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2015-2019 (project No. S1511014 [to Y.O., T.T., and Y.G.).
 Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest.


© 2021  American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 147 - N° 5

P. 1878-1891 - mai 2021 Retour au numéro
Article précédent Article précédent
  • Trained immunity and tolerance in innate lymphoid cells, monocytes, and dendritic cells during allergen-specific immunotherapy
  • Andrzej Eljaszewicz, Fiorella Ruchti, Urszula Radzikowska, Anna Globinska, Tadech Boonpiyathad, Anna Gschwend, Hideaki Morita, Arthur Helbling, Stefania Arasi, Helga Kahlert, Nadine Berek, Andreas Nandy, Mübeccel Akdis, Christoph Willers, Marcin Moniuszko, Cezmi A. Akdis, Milena Sokolowska
| Article suivant Article suivant
  • Airway macrophage-intrinsic TGF-?1 regulates pulmonary immunity during early-life allergen exposure
  • William J. Branchett, James Cook, Robert A. Oliver, Nicoletta Bruno, Simone A. Walker, Helen Stölting, Matthias Mack, Anne O’Garra, Sejal Saglani, Clare M. Lloyd

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.